Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Asn-Asp)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003565 AN005858 Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003213 AN005269 The central role of creatine and polyamines in fetal growth restriction Placenta Human Placenta disease University of Udine LC-MS
ST003179 AN005222 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003144 AN005159 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002926 AN004798 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University LC-MS
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University LC-MS
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
ST002512 AN004137 Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta Intestine Mouse University of California, San Francisco LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002407 AN003924 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract Intestine Human University of California, Davis LC-MS
ST002108 AN003448 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002107 AN003446 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002106 AN003445 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002094 AN003422 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST001794 AN002912 Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples Jejunum Human University of California, Davis LC-MS
ST001304 AN002172 Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii Fibroblast cells Toxoplasma gondii Parasitic infection Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001175 AN001950 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST000546 AN000832 Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium Cells Plasmodium falciparum Malaria Monash University LC-MS
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
  logo